No Data
Degenerative Disc Disease Market to Observe Stupendous Growth at ~19% CAGR by 2036, Due to Launch of Novel Drug Classes Such as Cell Replacement, NF-kappa B Inhibitors, Cartilage Regeneration via TGF-β1 Expression, and Others | DelveInsight
BioRestorative Therapies Overhauls Leadership and Board Governance
Express News | BioRestorative Therapies - Appoints Katharyn Field as CEO, President, and Interim CFO Effective July 13, 2026 - SEC Filing
Express News | BioRestorative Therapies - Appoints Katharyn Field as Interim CFO, Treasurer, and Secretary Effective July 13, 2026 - SEC Filing
Express News | BioRestorative Therapies - Robert Kristal Resigns as CFO and All Other Positions Effective July 13, 2026 - SEC Filing
Express News | BioRestorative Therapies - Lance Alstodt Resigns as President, CEO, Chairman and All Other Positions Effective July 13, 2026 - SEC Filing